tiprankstipranks
Firebrick Pharma Limited (AU:FRE)
ASX:FRE
Australian Market
Want to see AU:FRE full AI Analyst Report?

Firebrick Pharma Limited (FRE) Technical Analysis

8 Followers

Summary of all the Indicators

Overall Consensus
Buy
14Bullish
3Neutral
4Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Firebrick Pharma Limited’s (FRE) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Firebrick Pharma Limited is a Sell.
Firebrick Pharma Limited’s (FRE) 20-Day exponential moving average is 0.06, while Firebrick Pharma Limited’s (FRE) share price is <AU$0.1, making it a Buy.
Firebrick Pharma Limited’s (FRE) 50-Day exponential moving average is 0.06, while Firebrick Pharma Limited’s (FRE) share price is <AU$0.1, making it a Buy.

Firebrick Pharma Limited (FRE) Pivot Points

May 01, 2026, 05:51 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.05
0.06
0.06
0.06
0.06
0.07
0.07
Fibonacci
0.06
0.06
0.06
0.06
0.07
0.07
0.07
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Firebrick Pharma Limited (FRE) Moving Averages

May 01, 2026, 05:51 AM
Period
Simple
Exponential
MA5
0.06Buy
0.06Buy
MA10
0.06Buy
0.06Buy
MA20
0.06Buy
0.06Buy
MA50
0.06Buy
0.06Buy
MA100
0.06Buy
0.06Buy
MA200
0.06Buy
0.06Buy
Firebrick Pharma Limited’s (FRE) 10-Day exponential moving average is 0.06, while Firebrick Pharma Limited’s (FRE) share price is <AU$0.1, making it a Buy.
Firebrick Pharma Limited’s (FRE) 100-Day exponential moving average is 0.06, while Firebrick Pharma Limited’s (FRE) share price is <AU$0.1, making it a Buy.
Firebrick Pharma Limited’s (FRE) stock price is <AU$0.1 and Firebrick Pharma Limited’s (FRE) 50-day simple moving average is 0.06, creating a Buy signal.
Firebrick Pharma Limited’s (FRE) stock price is <AU$0.1 and Firebrick Pharma Limited’s (FRE) 100-day simple moving average is 0.06, creating a Buy signal.
Firebrick Pharma Limited’s (FRE) stock price is <AU$0.1 and Firebrick Pharma Limited’s (FRE) 200-day simple moving average is 0.06, creating a Buy signal.

Firebrick Pharma Limited (FRE) Technical Indicators

May 01, 2026, 05:51 AM
Name
Value
Implied Action
RSI (14)
58.68
Neutral
STOCH (9,6)
80.39
Sell
STOCHRSI (14)
81.48
Sell
MACD (12,26)
<0.01
Sell
ADX (14)
34.29
Neutral
Williams %R
0.00
Buy
CCI (14)
147.55
Sell
ATR (14)
<0.01
-
Ultimate Oscillator
53.88
Neutral
ROC
40.00
Buy
Firebrick Pharma Limited’s (FRE) Relative Strength Index (RSI) is 58.68, creating a Neutral signal.
Firebrick Pharma Limited’s (FRE) Trend Strength Indicator (ADX) is 34.29, creating a Neutral signal.
Firebrick Pharma Limited’s (FRE) Commodity Channel Index (CCI) is 147.55, creating a Sell signal.
Firebrick Pharma Limited’s (FRE) Price Rate of Change (ROC) is 40.00, creating a Buy signal.

FAQ

Is FRE a Buy, Hold, or Sell?
Based on FRE’s technical indicators, FRE is a Buy.
    What is FRE’s RSI (14)?
    FRE’s RSI (14) is 58.68, which suggests FRE is a Neutral.
      What is FRE’s MACD?
      FRE’s MACD is <0.01, which suggests FRE is a Sell.
        What is FRE’s 5-day moving average?
        FRE’s 5-day moving average is 0.06, which suggests FRE is a Buy.
          What is FRE’s 20-day moving average?
          FRE 20-day moving average is 0.06, which suggests FRE is a Buy.
            What is FRE’s 50-day moving average?
            FRE’s 50-day moving average is 0.06, which suggests FRE is a Buy.
              What is FRE’s 200-day moving average?
              FRE’s 200-day moving average is 0.06, which suggests FRE is a Buy.
                What is FRE’s Williams % R (14)?
                FRE’s Williams % R (14) is 0.00, which suggests FRE is a Buy.
                  What is FRE’s CCI (14)?
                  FRE’s CCI (14) is 147.55, which suggests FRE is a Sell.
                    What is the share price of Firebrick Pharma Limited?